Clinical characteristics for the relationship between type-2 diabetes mellitus and cognitive impairment: A cross-sectional study

Aging and Disease

Volumn 6, Issue 4, 2015, Pages 236-244

  Zhou, Yi ^a   Fang, Rong ^a   Liu, Li Hua ^b   Chen, Sheng Di ^a   Tang, Hui Dong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Department of Neurology The People's Hospital of Jurong City   (China)

Author keywords

Blood glucose; C peptide; Mild cognitive impairment; Type 2 diabetes mellitus

Indexed keywords

APOLIPOPROTEIN E4; C PEPTIDE; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; METFORMIN; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ACTIVITY OF DAILY LIVING ASSESSMENT; ADULT; AGED; ALLELE; ARTICLE; AUDITORY VERBAL LEARNING TEST; CLINICAL FEATURE; COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; FEMALE; GENOTYPE; GLUCOSE METABOLISM; HUMAN; LEARNING TEST; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; STROOP COLOR WORDS TEST;

EID: 84937855389     PISSN: None     EISSN: 21525250     Source Type: Journal    
DOI: 10.14336/AD.2014.1004     Document Type: Article

References (37)

1. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM (1999). Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology, 53: 1937-1942.
2. Velayudhan L, Poppe M, Archer N, Proitsi P, Brown RG, Lovestone S (2010). Risk of developing dementia in people with diabetes and mild cognitive impairment. The British journal of psychiatry: the journal of mental science, 196: 36-40.
3. Luchsinger JA, Reitz C, Patel B, Tang MX, Manly JJ, Mayeux R (2007). Relation of diabetes to mild cognitive impairment. Archives of neurology, 64: 570-575.
4. Cheng G, Huang C, Deng H, Wang H (2012). Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Internal medicine journal, 42: 484-491.
5. Kidd PM (2008). Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention. Alternative medicine review: a journal of clinical therapeutic, 13: 85-115.
6. Samaras K, Sachdev PS (2012). Diabetes and the elderly brain: sweet memories? Therapeutic advances in endocrinology and metabolism, 3: 189-196.
7. Sima AA, Kamiya H, Li ZG (2004). Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes. European journal of pharmacology, 490: 187-197.
8. Martins IJ, Hone E, Foster JK, Sunram-Lea SI, Gnjec A, Fuller SJ, et al. (2006). Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease. Molecular psychiatry, 11: 721-736.
9. Bornstein NM, Brainin M, Guekht A, Skoog I, Korczyn AD (2014). Diabetes and the brain: issues and unmet needs. Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 35: 995-1001.
10. Umegaki H (2014). Type 2 diabetes as a risk factor for cognitive impairment: current insights. Clinical interventions in aging, 9: 1011-1019.
11. Alberti KG, Zimmet PZ (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic medicine: a journal of the British Diabetic Association, 15: 539-553.
12. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999). Mild cognitive impairment: clinical characterization and outcome. Archives of neurology, 56: 303-308.
13. Ma J, Zhou Y, Xu J, Liu X, Wang Y, Deng Y, et al. (2014). Association study of TREM2 polymorphism rs75932628 with late-onset Alzheimer's disease in Chinese Han population. Neurological research: 1743132814Y0000000376.
14. Dahlbeck JW, McCluney KW, Yeakley JW, Fenstermacher MJ, Bonmati C, Van Horn G, 3rd, et al. (1991). The interuncal distance: a new MR measurement for the hippocampal atrophy of Alzheimer disease. AJNR. American journal of neuroradiology, 12: 931-932.
15. Mu Q, Xie J, Wen Z, Weng Y, Shuyun Z (1999). A quantitative MR study of the hippocampal formation, the amygdala, and the temporal horn of the lateral ventricle in healthy subjects 40 to 90 years of age. AJNR. American journal of neuroradiology, 20: 207-211.
16. Cui GH, Yao YH, Xu RF, Tang HD, Jiang GX, Wang Y, et al. (2011). Cognitive impairment using education-based cutoff points for CMMSE scores in elderly Chinese people of agricultural and rural Shanghai China. Acta neurologica Scandinavica, 124: 361-367.
17. Guo Q, Zhao Q, Chen M, Ding D, Hong Z (2009). A comparison study of mild cognitive impairment with 3 memory tests among Chinese individuals. Alzheimer disease and associated disorders, 23: 253-259.
18. Morris JC (1993). The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology, 43: 2412-2414.
19. Guo Q HZ, Lv C, et al. (2005). Application of Stroop color-word test on Chinese elderly patients with mild cognitive impairment and mild Alzheimer's dementia. Chin J Neuromed, 4: 701-704.
20. Zhao WQ, Alkon DL (2001). Role of insulin and insulin receptor in learning and memory. Molecular and cellular endocrinology, 177: 125-134.
21. Derakhshan F, Toth C (2013). Insulin and the brain. Current diabetes reviews, 9: 102-116.
22. Muller AP, Gnoatto J, Moreira JD, Zimmer ER, Haas CB, Lulhier F, et al. (2011). Exercise increases insulin signaling in the hippocampus: physiological effects and pharmacological impact of intracerebroventricular insulin administration in mice. Hippocampus, 21: 1082-1092.
23. Niwa H, Koumoto C, Shiga T, Takeuchi J, Mishima S, Segawa T, et al. (2006). Clinical analysis of cognitive function in diabetic patients by MMSE and SPECT. Diabetes research and clinical practice, 72: 142-147.
24. Xia W, Wang S, Sun Z, Bai F, Zhou Y, Yang Y, et al. (2013). Altered baseline brain activity in type 2 diabetes: a resting-state fMRI study. Psychoneuroendocrinology, 38: 2493-2501.
25. Hills CE, Brunskill NJ (2009). Cellular and physiological effects of C-peptide. Clinical science, 116: 565-574.
26. Sima AA (2003). C-peptide and diabetic neuropathy. Expert opinion on investigational drugs, 12: 1471-1488.
27. Shpakov AO, Granstrem OK (2013). [C-peptide physiological effects]. Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova/Rossiiskaia akademiia nauk, 99: 196-211.
28. Shpakov AO, Granstrem AO (2013). [C-peptide structure, functions and molecular mechanisms of action]. Tsitologiia, 55: 16-27.
29. Crane PK, Walker R, Larson EB (2013). Glucose levels and risk of dementia. The New England journal of medicine, 369: 1863-1864.
30. Kerti L, Witte AV, Winkler A, Grittner U, Rujescu D, Floel A (2013). Higher glucose levels associated with lower memory and reduced hippocampal microstructure. Neurology, 81: 1746-1752.
31. Mortby ME, Janke AL, Anstey KJ, Sachdev PS, Cherbuin N (2013). High "normal" blood glucose is associated with decreased brain volume and cognitive performance in the 60s: the PATH through life study. PloS one, 8: e73697.
32. Roberts RO, Geda YE, Knopman DS, Christianson TJ, Pankratz VS, Boeve BF, et al. (2008). Association of duration and severity of diabetes mellitus with mild cognitive impairment. Archives of neurology, 65: 1066-1073.
33. Plastino M, Fava A, Pirritano D, Cotronei P, Sacco N, Sperli T, et al. (2010). Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2. Journal of the neurological sciences, 288: 112-116.
34. Beeri MS, Schmeidler J, Silverman JM, Gandy S, Wysocki M, Hannigan CM, et al. (2008). Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology. Neurology, 71: 750-757.
35. He L, Sabet A, Djedjos S, Miller R, Sun X, Hussain MA, et al. (2009). Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein. Cell, 137: 635-646.
36. Labuzek K, Suchy D, Gabryel B, Bielecka A, Liber S, Okopien B (2010). Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide. Pharmacological reports: PR, 62: 956-965.
37. Pintana H, Apaijai N, Pratchayasakul W, Chattipakorn N, Chattipakorn SC (2012). Effects of metformin on learning and memory behaviors and brain mitochondrial functions in high fat diet induced insulin resistant rats. Life sciences, 91: 409-414.